Black Beret Life Sciences
2
23M
2
0.29
1
- Stages of investment
- Areas of investment
Summary
Black Beret Life Sciences appeared to be the VC, which was created in 2014. The fund was located in North America if to be more exact in United States. Black Beret Life Sciences appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the Houston.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Diasome, Affigen. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Black Beret Life Sciences, startups are often financed by Quaker BioVentures, Devon Park BioVentures. The meaningful sponsors for the fund in investment in the same round are Medicxi Ventures, McDonald Partners, JDRF T1D Fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.29
- Investments by industry
- Medical (2)
- Biotechnology (2)
- Health Care (1)
- Therapeutics (1)
- Life Science (1) Show 1 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Affigen | 21 Feb 2017 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 17M | United States, Missouri, City of Saint Louis |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.